TNF and Insulin resistance: TNF-α inhibits IRS-1 phosphorylation, reducing insulin signaling and glucose uptake.  IL-6 promotes hepatic insulin resistance via gluconeogenesis and glycogenolysis.  Chronic low-grade inflammation exacerbates insulin resistance and metabolic dysfunction in GD.